Clinical implication of 18F-FDG PET/CT in carcinoma of unknown primary

Neoplasma

Volumn 58, Issue 2, 2011, Pages 135-139

  Pak, K ^a   Kim, S J ^a   Kim, I J ^a   Nam, H Y ^a   Kim, B S ^a   Kim, K ^a   Kim, Y K ^b  

^a Pusan National University Hospital   (South Korea)

^b Kim Yong Ki Internal Medicine Clinic   (South Korea)

Author keywords

Fluorodeoxyglucose F18; Neoplasms; Positron emission tomography; Unknown primary

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTIVE VALUE; PRIMARY TUMOR; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY;

ADULT; AGED; DIAGNOSTIC ERRORS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79961125789     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_02_135     Document Type: Article

References (27)

1. PAVLIDIS N, FIZAZI K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005; 54: 243-250. doi:10.1016/ j.critrevonc.2004.10.002
2. FENCL P, BELOHLAVEK O, SKOPALOVA M, JARUSKOVA M, KANTOROVA I, et al. Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2007; 34: 1783-1792. doi:10.1007/s00259-007-0456-8
3. PAVLIDIS N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007; 46: 592-601. doi:10.1080/02841860701243095
4. PAVLIDIS N, BRIASOULIS E, HAINSWORTH J, GRECO FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990-2005. doi:10.1016/S0959-8049(03)00547-1
5. OIEN K, STEWART I, EVANS T. Unknown primary. The Cancer Handbook 2nd Edition. Wiley Interscience 2007; 852
6. HAAS I, HOFFMANN TK, ENGERS R, GANZER U. Diag-nostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 2002; 259: 325-333.
7. VAN DE WOUW AJ, JANSEN RL, SPEEL EJ, HILLEN HF. The unknown biology of the unknown primary tumour: a literature review. Ann Oncol. 2003; 14: 191-196. doi:10.1093/ annonc/mdg068
8. AMBROSINI V, NANNI C, RUBELLO D, MORETTI A, BATTISTA G, et al. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med. 2006; 111: 1146-1155. doi:10.1007/s11547-006-0112-6
9. SCOTT CL, KUDABA I, STEWART JM, HICKS RJ, RISCHIN D. The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol. 2005; 7: 236-243. doi:10.1007/ s11307-005-4114-x
10. KOLE AC, NIEWEG OE, PRUIM J, HOEKSTRA HJ, KOOPS HS, et al. Detection of Unknown Occult Primary Tumors Using Positron Emission Tomography. Cancer 1998; 82: 1160-66. doi:10.1002/(SICI)1097-0142(19980315)82:6<1160:: AID-CNCR22>3.0.CO;2-3
11. YAPAR Z, KIBAR M, YAPAR AF, PAYDAS S, REYHAN M, et al. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Nucl Med Commun. 2010; 31: 59-66. doi:10.1097/MNM.0b013e328332b340
12. ALBERINI JL, BELHOCINE T, HUSTINX R, DAENEN F, RIGO P. Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nucl Med Commun. 2003; 24: 1081-1086. doi:10.1097/00006231-200310000-00008
13. WARBURG O. On the origin of cancer cells. Science. 1956; 123: 309-314. doi:10.1126/science.123.3191.309
14. FLETCHER JW, DJULBEGOVIC B, SOARES HP, SIEGEL BA, LOWE VJ, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008; 49: 480-508. doi:10.2967/ jnumed.107.047787
15. BOHUSLAVIZKI KH, KLUTMANN S, KRÖGER S, SONNEMANN U, BUCHERT R, et al. FDG PET detection of unknown primary tumors. J Nucl Med. 2000; 41: 816-822.
16. KOLESNIKOV-GAUTHIER H, LEVY E, MERLET P, KIROVA J, SYROTA A, et al. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun. 2005; 26: 1059-1066. doi:10.1097/00006231-200512000-00003
17. AMBROSINI V, NANNI C, RUBELLO D, MORETTI A, BATTISTA G, et al. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin. Radiol Med. 2006; 111: 1146-1155. doi:10.1007/s11547-006-0112-6
18. ROH JL, KIM JS, LEE JH, CHO KJ, CHOI SH, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol. 2009; 45: 218-224. doi:10.1016/j.oraloncology.2008.05.010
19. FOGARTY GB, PETERS LJ, STEWART J, SCOTT C, RISCHIN D, HICKS RJ. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003; 25: 138-145. doi:10.1002/hed.10191
20. HUMM JL, ROSENFELD A, DEL GUERRA A. From PET detectors to PET scanners. Eur J Nucl Med Mol Imaging. 2003; 30: 1574-1597.
21. SORET M, BACHARACH SL, BUVAT I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007; 48: 932-945. doi:10.2967/jnumed.106.035774
22. CHOROST MI, LEE MC, YEOH CB, MOLINA M, GHOSH BC. Unknown primary. J Surg Oncol. 2004; 87: 191-203.
23. NARESH KN. Do metastatic tumours from an unknown primary reflect angiogenic incompetence of the tumour at the primary site? a hypothesis. Med Hypotheses. 2002; 59: 357-360. doi:10.1016/S0306-9877(02)00221-9
24. NYSTROM JS, WEINER JM, HEFFELFINGER-JUTTNER J, IRWIN LE, BATEMAN JR, WOLF RM. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol. 1977; 4: 53-58.
25. LU P, YU L, LI Y, SUN Y. A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer. Nucl Med Commun. 2010; 31: 646-651.
26. GUTZEIT A, ANTOCH G, KÜHL H, EGELHOF T, FISCHER M, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology. 2005; 234: 227-234. doi:10.1148/radiol.2341031554
27. EASTERBROOK PJ, BERLIN JA, GOPALAN R, MATTHEWS DR. Publication bias in clinical research. Lancet. 1991; 337: 867-872.